Cargando…
First external quality assurance program for bloodstream Real-Time PCR monitoring of treatment response in clinical trials of Chagas disease
Real-Time PCR (qPCR) testing is recommended as both a diagnostic and outcome measurement of etiological treatment in clinical practice and clinical trials of Chagas disease (CD), but no external quality assurance (EQA) program provides performance assessment of the assays in use. We implemented an E...
Autores principales: | Ramírez, Juan C., Parrado, Rudy, Sulleiro, Elena, de la Barra, Anabelle, Rodríguez, Marcelo, Villarroel, Sandro, Irazu, Lucía, Alonso-Vega, Cristina, Alves, Fabiana, Curto, María A., García, Lineth, Ortiz, Lourdes, Torrico, Faustino, Gascón, Joaquim, Flevaud, Laurence, Molina, Israel, Ribeiro, Isabela, Schijman, Alejandro G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703561/ https://www.ncbi.nlm.nih.gov/pubmed/29176887 http://dx.doi.org/10.1371/journal.pone.0188550 |
Ejemplares similares
-
Genetic polymorphism of Trypanosoma cruzi bloodstream populations in adult chronic indeterminate Chagas disease patients from the E1224 clinical trial
por: Ramírez, Juan Carlos, et al.
Publicado: (2021) -
Usefulness of Serial Blood Sampling and PCR Replicates for Treatment Monitoring of Patients with Chronic Chagas Disease
por: Parrado, Rudy, et al.
Publicado: (2019) -
A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease
por: Torrico, Faustino, et al.
Publicado: (2022) -
Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: A systematic review and meta-analysis
por: Ciapponi, Agustín, et al.
Publicado: (2020) -
The burden of congenital Chagas disease and implementation of molecular diagnostic tools in Latin America
por: Picado, Albert, et al.
Publicado: (2018)